ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $828,690 | -8.8% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $908,960 | -1.6% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $924,000 | -4.4% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $967,000 | +7.9% | 23,000 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $896,000 | -2.3% | 23,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $917,000 | +10.3% | 23,000 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $831,000 | -52.9% | 23,000 | -46.5% | 0.00% | -66.7% |
| Q2 2021 | $1,763,000 | -58.1% | 43,000 | -55.4% | 0.00% | -62.5% |
| Q1 2021 | $4,209,000 | -12.9% | 96,500 | 0.0% | 0.01% | -20.0% |
| Q4 2020 | $4,830,000 | +27.6% | 96,500 | +7.2% | 0.01% | +25.0% |
| Q3 2020 | $3,786,000 | +11.4% | 90,000 | +28.6% | 0.01% | 0.0% |
| Q2 2020 | $3,398,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |